Infectious Mononucleosis (Epstein-Barr Virus - HHV-4)

Overview

Plain-Language Overview

Infectious Mononucleosis (Epstein-Barr Virus - HHV-4) is a common viral infection that mainly affects the immune system and causes symptoms like fever, sore throat, and swollen lymph nodes. It primarily involves the lymphatic system, which helps the body fight infections. The virus spreads through saliva, often called the kissing disease, and leads to fatigue and enlarged tonsils. Most people recover fully, but the illness can cause significant tiredness and discomfort for several weeks. The infection triggers the body’s immune response, which is responsible for many of the symptoms.

Clinical Definition

Infectious Mononucleosis (IM) is an acute lymphoproliferative disorder caused by primary infection with Epstein-Barr Virus (EBV), a member of the Herpesviridae family (HHV-4). The virus infects B lymphocytes and epithelial cells, leading to a robust cytotoxic T cell response that causes characteristic symptoms. IM is characterized by fever, pharyngitis, and lymphadenopathy, often with splenomegaly and atypical lymphocytosis. The disease is significant due to its potential complications, including splenic rupture and secondary bacterial infections. EBV establishes lifelong latency in B cells, with possible reactivation. Diagnosis and understanding of IM are critical for managing symptoms and preventing complications.

Inciting Event

Transmission occurs via saliva exchange during kissing, sharing utensils, or close contact.
Initial infection of oropharyngeal epithelial cells followed by B cell infection.
Exposure to EBV-containing saliva from an infected individual triggers disease onset.

Latency Period

Symptoms typically develop 4 to 6 weeks after initial EBV exposure.
The incubation period reflects time for viral replication and immune activation.
Latency allows for viral dissemination to lymphoid tissues before symptom onset.

Diagnostic Delay

Early symptoms mimic common viral illnesses leading to misdiagnosis as streptococcal pharyngitis or influenza.
Lack of awareness of classic triad (fever, pharyngitis, lymphadenopathy) delays suspicion.
False-negative or delayed heterophile antibody test results can postpone diagnosis.
Overlap with other causes of lymphadenopathy and fatigue complicates clinical recognition.

Clinical Presentation

Signs & Symptoms

Fever, sore throat, and fatigue are the classic triad of infectious mononucleosis.
Pharyngitis with tonsillar exudates mimics streptococcal infection but is often more severe.
Posterior cervical lymphadenopathy is a distinguishing clinical feature.
Splenomegaly causes left upper quadrant discomfort or fullness.
Headache and malaise are common systemic symptoms.

History of Present Illness

Initial presentation includes gradual onset of fever, sore throat, and malaise over several days.
Progression to marked cervical lymphadenopathy and tonsillar enlargement with exudates is common.
Patients often report fatigue and myalgias lasting weeks.
Splenomegaly may cause left upper quadrant discomfort or fullness.
Symptoms typically peak within 1 to 2 weeks and resolve over 2 to 4 weeks.

Past Medical History

Prior immunosuppression or HIV infection may alter disease severity.
History of recurrent pharyngitis or tonsillitis can complicate clinical picture.
No prior EBV exposure or negative EBV serology indicates susceptibility.
Use of aminopenicillins during illness may cause characteristic rash.

Family History

No specific heritable syndromes are associated with infectious mononucleosis.
Family members may share exposure risk due to close contact but no genetic predisposition.
No increased incidence linked to familial immune disorders.

Physical Exam Findings

Posterior cervical lymphadenopathy is a hallmark finding in infectious mononucleosis.
Tonsillar enlargement with or without exudates is commonly observed.
Splenomegaly is frequently present and may be palpable below the left costal margin.
Hepatomegaly can occur but is less common than splenomegaly.
Maculopapular rash may develop, especially if the patient is treated with ampicillin or amoxicillin.

Diagnostic Workup

Diagnostic Criteria

Diagnosis is based on clinical presentation of fever, pharyngitis, and posterior cervical lymphadenopathy combined with laboratory findings of atypical lymphocytosis on peripheral smear. The heterophile antibody test (Monospot test) is a key confirmatory test, detecting antibodies produced in response to EBV infection. EBV-specific serologies, including viral capsid antigen (VCA) IgM and IgG, can further confirm acute infection. Elevated liver enzymes and splenomegaly on imaging support the diagnosis but are not definitive.

Pathophysiology

Key Mechanisms

Primary infection of B lymphocytes by Epstein-Barr virus (EBV) leads to latent viral persistence and polyclonal B cell activation.
Cytotoxic CD8+ T cell response against infected B cells causes characteristic lymphocytosis and tissue inflammation.
EBV-induced atypical lymphocytes represent activated CD8+ T cells responding to infected B cells.
Immune-mediated pharyngeal inflammation and lymphadenopathy result from local viral replication and immune cell infiltration.
Splenomegaly arises from proliferation of infected B cells and reactive hyperplasia in the spleen's white pulp.

Involvement	Details
Organs	Spleen is commonly enlarged and at risk for rupture due to lymphoid hyperplasia.
	Liver may be involved causing mild hepatitis and elevated transaminases.
	Pharynx shows inflammation and exudative tonsillitis as a hallmark clinical feature.
Tissues	Lymphoid tissue in the tonsils and lymph nodes undergoes hyperplasia due to immune activation.
Tissues	Spleen tissue becomes enlarged and fragile due to infiltration by infected and reactive immune cells.
Cells	B lymphocytes are the primary host cells infected by Epstein-Barr virus, leading to their proliferation and atypical activation.
	Cytotoxic CD8+ T cells expand to control infected B cells and contribute to lymphocytosis and symptoms.
	Natural killer cells participate in early antiviral defense against infected cells.
Chemical Mediators	Interferon-gamma is produced by activated T cells and helps control viral replication.
	Cytokines such as IL-1, IL-6, and TNF-alpha mediate systemic symptoms like fever and malaise.
	Heterophile antibodies are produced by B cells and serve as a diagnostic marker.

Treatments

Pharmacological Treatments

Acetaminophen
- Mechanism:
  - Inhibits central prostaglandin synthesis to reduce fever and pain.
- Side effects:
  - Hepatotoxicity with overdose
  - Rare allergic reactions
- Clinical role:
  - First-line
NSAIDs
- Mechanism:
  - Inhibit cyclooxygenase enzymes to reduce inflammation, fever, and pain.
- Side effects:
  - Gastrointestinal irritation
  - Renal impairment
  - Increased bleeding risk
- Clinical role:
  - Supportive

Non-pharmacological Treatments

Rest and hydration to support immune function and recovery.
Avoidance of contact sports to prevent splenic rupture due to splenomegaly.

Prevention

Pharmacological Prevention

No approved vaccine or antiviral prophylaxis exists for Epstein-Barr virus (EBV) infection.
Antiviral agents like acyclovir have limited efficacy and are not routinely used for prevention.

Non-pharmacological Prevention

Avoiding saliva exchange (e.g., kissing, sharing utensils) reduces transmission risk.
Good hand hygiene and respiratory etiquette help prevent spread of EBV.
Avoiding contact sports during acute illness reduces risk of splenic rupture.
Educating patients about symptom recognition and early medical evaluation can prevent complications.

Outcome & Complications

Complications

Splenic rupture is a rare but life-threatening complication requiring urgent intervention.
Airway obstruction from severe tonsillar hypertrophy may necessitate corticosteroids or airway management.
Hemolytic anemia and thrombocytopenia can occur due to immune-mediated mechanisms.
Neurologic complications such as Guillain-Barré syndrome or meningoencephalitis are rare.
Chronic fatigue syndrome may develop following acute infection.

Short-term Sequelae	Long-term Sequelae
Prolonged fatigue lasting weeks to months is common after acute illness. Persistent lymphadenopathy may remain for several weeks. Mild hepatitis with elevated liver enzymes usually resolves spontaneously. Pharyngeal discomfort can persist despite resolution of infection.	Chronic active EBV infection is rare but can cause ongoing systemic symptoms. Increased risk of certain lymphomas, such as Burkitt lymphoma and Hodgkin lymphoma, is associated with EBV. Autoimmune disorders like hemophagocytic lymphohistiocytosis (HLH) may develop in predisposed individuals. Post-viral fatigue syndrome can persist for months after infection.

Differential Diagnoses

Infectious Mononucleosis (Epstein-Barr Virus - HHV-4) versus Cytomegalovirus (CMV) Mononucleosis

Infectious Mononucleosis (Epstein-Barr Virus - HHV-4)	Cytomegalovirus (CMV) Mononucleosis
Primarily transmitted through saliva, especially in adolescents and young adults	Often transmitted via body fluids including urine and saliva, common in immunocompromised hosts
Heterophile antibody test positive in most cases	Heterophile antibody test usually negative
Marked lymphocytosis with abundant atypical lymphocytes	Lymphocytosis with atypical lymphocytes less prominent
Positive EBV viral capsid antigen IgM or heterophile antibody	Positive CMV-specific IgM or PCR

Infectious Mononucleosis (Epstein-Barr Virus - HHV-4) versus Acute HIV Infection

Infectious Mononucleosis (Epstein-Barr Virus - HHV-4)	Acute HIV Infection
Close contact with saliva or respiratory secretions, often via kissing	Recent high-risk sexual exposure or needle sharing
Gradual onset of fever, pharyngitis, and lymphadenopathy	Rapid progression to systemic symptoms including rash and mucocutaneous ulcers
Positive heterophile antibody, normal HIV RNA	Markedly elevated HIV RNA viral load, negative heterophile antibody
Positive EBV serology with viral capsid antigen IgM	Positive HIV antigen/antibody test or HIV PCR

Infectious Mononucleosis (Epstein-Barr Virus - HHV-4) versus Streptococcal Pharyngitis

Infectious Mononucleosis (Epstein-Barr Virus - HHV-4)	Streptococcal Pharyngitis
Negative rapid strep test, positive heterophile antibody	Positive rapid antigen detection test or throat culture for group A Streptococcus
Gradual onset with prominent lymphadenopathy and atypical lymphocytosis	Abrupt onset of sore throat, fever, and tonsillar exudates without significant lymphocytosis
Supportive care; antibiotics not routinely indicated	Rapid symptom improvement with beta-lactam antibiotics

Infectious Mononucleosis (Epstein-Barr Virus - HHV-4) versus Toxoplasmosis

Infectious Mononucleosis (Epstein-Barr Virus - HHV-4)	Toxoplasmosis
Exposure to saliva from infected individuals	Exposure to cat feces or undercooked meat
Positive EBV viral capsid antigen IgM and heterophile antibody	Positive Toxoplasma IgM and IgG antibodies
Prominent pharyngitis and generalized lymphadenopathy	Mild or absent pharyngitis, often asymptomatic or mild lymphadenopathy

Infectious Mononucleosis (Epstein-Barr Virus - HHV-4) versus Acute Viral Hepatitis

Infectious Mononucleosis (Epstein-Barr Virus - HHV-4)	Acute Viral Hepatitis
Mild to moderate transaminase elevation	Markedly elevated transaminases (AST and ALT often >1000 U/L)
Predominant pharyngitis, lymphadenopathy, and splenomegaly	Predominant jaundice and hepatomegaly with systemic symptoms
Positive EBV serology and heterophile antibody	Positive hepatitis serologies (HAV, HBV, HCV)